<DOC>
	<DOCNO>NCT00092651</DOCNO>
	<brief_summary>The purpose study evaluate lipid lower effect investigational drug patient hypercholesterolemia ( high cholesterol ) .</brief_summary>
	<brief_title>A Study MK0653A ( Ezetimibe ( + ) Simvastatin ) Patients With Hypercholesterolemia ( 0653A-038 )</brief_title>
	<detailed_description>The duration treatment 4 month .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Ezetimibe , Simvastatin Drug Combination</mesh_term>
	<criteria>High cholesterol Patient condition , opinion investigator , might pose risk patient , interfere participation study , meet additional criterion require study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Primary hypercholesterolemia</keyword>
</DOC>